Endoplasmic reticulum stress contributes to prediabetic peripheral neuropathy

Experimental Neurology

Volumn 247, Issue , 2013, Pages 342-348

  Lupachyk, Sergey ^a   Watcho, Pierre ^a   Obrosov, Alexander A ^a   Stavniichuk, Roman ^a   Obrosova, Irina G ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Diabetic peripheral neuropathy; Endoplasmic reticulum stress; Eukaryotic initiation factor 2 ; High fat diet fed mouse; Motor nerve conduction velocity; Prediabetic peripheral neuropathy; Salubrinal; Sensory nerve conduction velocity; Streptozotocin; Trimethylamine oxide; Unfolded protein response; Zucker (fa fa) rat

Indexed keywords

CHAPERONE; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; INITIATION FACTOR 2ALPHA; TRIMETHYLAMINE OXIDE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; HYPOALGESIA; IMPAIRED GLUCOSE TOLERANCE; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OBESITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN UNFOLDING; RAT; SCIATIC NERVE; SENSORY NERVE CONDUCTION; UPREGULATION;

DIABETIC PERIPHERAL NEUROPATHY; ENDOPLASMIC RETICULUM STRESS; EUKARYOTIC INITIATION FACTOR-2Α; HIGH-FAT DIET FED MOUSE; MOTOR NERVE CONDUCTION VELOCITY; PREDIABETIC PERIPHERAL NEUROPATHY; SALUBRINAL; SENSORY NERVE CONDUCTION VELOCITY; STREPTOZOTOCIN; TRIMETHYLAMINE OXIDE; UNFOLDED PROTEIN RESPONSE; ZUCKER (FA/FA) RAT;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ENDOPLASMIC RETICULUM STRESS; FATTY ACIDS; GLUCOSE TOLERANCE TEST; INSULIN; LIPIDS; MALE; MICE; MICE, INBRED C57BL; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDIABETIC STATE; RATS; RATS, ZUCKER; SCIATIC NERVE; SPINAL CORD;

EID: 84881371523     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.11.001     Document Type: Article

References (65)

1. Bonadonna R.C., Cucinotta D., Fedele D., Riccardi G., Tiengo A. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 2006, 29:2701-2707.
2. Boulton A.J., Vinik A.I., Arezzo J.C., Bril V., Feldman E.L., Freeman R., Malik R.A., Maser R.E., Sosenko J.M., Ziegler D. American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005, 28:956-962.
3. Boyce M., Bryant K.F., Jousse C., Long K., Harding H.P., Scheuner D., Kaufman R.J., Ma D., Coen D.M., Ron D., Yuan J. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 2005, 307:935-939.
4. Cnop M., Ladriere L., Hekerman P., Ortis F., Cardozo A.K., Dogusan Z., Flamez D., Boyce M., Yuan J., Eizirik D.L. Selective inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic beta-cell dysfunction and apoptosis. J. Biol. Chem. 2007, 282:3989-3997.
5. Coppey L., Davidson E., Lu B., Gerard C., Yorek M. Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice. Neuropharmacology 2011, 60:259-266.
6. Costa L.A., Canani L.H., LisbÔa H.R., Tres G.S., Gross J.L. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet. Med. 2004, 21:252-255.
7. Drel V.R., Pacher P., Vareniuk I., Pavlov I.A., Ilnytska O., Lyzogubov V.V., Bell S.R., Groves J.T., Obrosova I.G. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes. Int. J. Mol. Med. 2007, 20:783-792.
8. Drel V.R., Lupachyk S., Shevalye H., Vareniuk I., Xu W., Zhang J., Delamere N.A., Shahidullah M., Slusher B., Obrosova I.G. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}. Endocrinology 2010, 151:2547-2555.
9. Dyck P.J., Dyck P.J., Klein C.J., Weigand S.D. Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study. Muscle Nerve 2007, 36:536-541.
10. Eizirik D.L., Cardozo A.K., Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 2008, 29:42-61.
11. Fu S., Yang L., Li P., Hofmann O., Dicker L., Hide W., Lin X., Watkins S.M., Ivanov A.R., Hotamisligil G.S. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 2011, 473:528-531.
12. Fu S., Watkins S.M., Hotamisligil G.S. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab. 2012, 15:623-634.
13. Henriksen E.J., Diamond-Stanic M.K., Marchionne E.M. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic. Biol. Med. 2011, 51:993-999.
14. Hoehn K.L., Salmon A.B., Hohnen-Behrens C., Turner N., Hoy A.J., Maghzal G.J., Stocker R., Van Remmen H., Kraegen E.W., Cooney G.J., Richardson A.R., James D.E. Insulin resistance is a cellular antioxidant defense mechanism. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:17787-17792.
15. Hotamisligil G.S. Endoplasmic reticulum stress and atherosclerosis. Nat. Med. 2010, 16:396-399.
16. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
17. Hummasti S., Hotamisligil G.S. Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ. Res. 2010, 107:579-591.
18. Isomaa B., Henricsson M., Almgren P., Tuomi T., Taskinen M.R., Groop L. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 2001, 44:1148-1154.
19. Kars M., Yang L., Gregor M.F., Mohammed B.S., Pietka T.A., Finck B.N., Patterson B.W., Horton J.D., Mittendorfer B., Hotamisligil G.S., Klein S. Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 2010, 59:1899-1905.
20. Kato N., Mizuno K., Makino M., Suzuki T., Yagihashi S. Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats. Diabetes Res. Clin. Pract. 2000, 50:77-85.
21. Kaufman R.J., Back S.H., Song B., Han J., Hassler J. The unfolded protein response is required to maintain the integrity of the endoplasmic reticulum, prevent oxidative stress and preserve differentiation in β-cells. Diabetes Obes. Metab. 2010, 2:99-107.
22. Kharroubi I., Ladrière L., Cardozo A.K., Dogusan Z., Cnop M., Eizirik D.L. Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 2004, 145:5087-5096.
23. Lauria G., Lombardi R., Borgna M., Penza P., Bianchi R., Savino C., Canta A., Nicolini G., Marmiroli P., Cavaletti G. Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J. Peripher. Nerv. Syst. 2005, 10:202-208.
24. Longo K.A., Govek E.K., Nolan A., McDonagh T., Charoenthongtrakul S., Giuliana D.J., Morgan K., Hixon J., Zhou C., Kelder B., Kopchick J.J., Saunders J.O., Navia M.A., Curtis R., DiStefano P.S., Geddes B.J. Pharmacologic inhibition of ghrelin receptor signaling is insulin sparing and promotes insulin sensitivity. J. Pharmacol. Exp. Ther. 2011, 339:115-124.
25. Lupachyk S., Watcho P., Hasanova N., Julius U., Obrosova I.G. Triglyceride, NEFA, and prediabetic neuropathy: role for oxidative-nitrosative stress. Free Radic. Biol. Med. 2012, 52:1255-1263.
26. Maris M., Overbergh L., Gysemans C., Waget A., Cardozo A.K., Verdrengh E., Cunha J.P., Gotoh T., Cnop M., Eizirik D.L., Burcelin R., Mathieu C. Deletion of C/EBP homologous protein (Chop) in C57Bl/6 mice dissociates obesity from insulin resistance. Diabetologia 2012, 55:1167-1178.
27. Muellenbach E.A., Diehl C.J., Teachey M.K., Lindborg K.A., Archuleta T.L., Harrell N.B., Andersen G., Somoza V., Hasselwander O., Matuschek M., Henriksen E.J. Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance in the obese Zucker rat. Metabolism 2008, 57:1465-1472.
28. Obrosova I.G., Li F., Abatan O.I., Forsell M.A., Komjáti K., Pacher P., Szabó C., Stevens M.J. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 2004, 53:711-720.
29. Obrosova I.G., Ilnytska O., Lyzogubov V.V., Pavlov I.A., Mashtalir N., Nadler J.L., Drel V.R. High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition. Diabetes 2007, 56:2598-2608.
30. Obrosova I.G., Xu W., Lyzogubov V.V., Ilnytska O., Mashtalir N., Vareniuk I., Pavlov I.A., Zhang J., Slusher B., Drel V.R. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. Free Radic. Biol. Med. 2008, 44:972-981.
31. Oltman C.L., Coppey L.J., Gellett J.S., Davidson E.P., Lund D.D., Yorek M.A. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E113-E122.
32. Oltman C.L., Davidson E.P., Coppey L.J., Kleinschmidt T.L., Lund D.D., Yorek M.A. Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin. Obesity 2008, 16:82-89. (Silver Spring).
33. Pallet N., Bouvier N., Bendjallabah A., Rabant M., Flinois J.P., Hertig A., Legendre C., Beaune P., Thervet E., Anglicheau D. Cyclosporine-induced endoplasmic reticulum stress triggers tubular phenotypic changes and death. Am. J. Transplant. 2008, 8:2283-2296.
34. Pittenger G.L., Mehrabyan A., Simmons K., Amandarice, Dublin C., Barlow P., Vinik A.I. Small fiber neuropathy is associated with the metabolic syndrome. Metab. Syndr. Relat. Disord. 2005, 3:113-121.
35. Saxena S., Cabuy E., Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 2009, 12:627-636.
36. Shertzer H.G., Schneider S.N., Kendig E.L., Clegg D.J., D'Alessio D.A., Genter M.B. Acetaminophen normalizes glucose homeostasis in mouse models for diabetes. Biochem. Pharmacol. 2008, 75:1402-1410.
37. Shevalye H., Lupachyk S., Watcho P., Stavniichuk R., Khazim K., Abboud H.E., Obrosova I.G. Prediabetic nephropathy as an early consequence of the high-calorie/high-fat diet: relation to oxidative stress. Endocrinology 2012, 153:1152-1161.
38. Shevalye H., Watcho P., Stavniichuk R., Dyukova E., Lupachyk S., Obrosova I.G. Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats. Diabetes 2012, 61:2126-2133.
39. Sims-Robinson C., Zhao S., Hur J., Feldman E.L. Central nervous system endoplasmic reticulum stress in a murine model of type 2 diabetes. Diabetologia 2012, 55:2276-2284.
40. Sinnreich M., Taylor B.V., Dyck P.J. Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist 2005, 11:63-79.
41. Smith A.G., Ramachandran P., Tripp S., Singleton J.R. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 2001, 57:1701-1704.
42. Smith A.G., Russell J., Feldman E.L., Goldstein J., Peltier A., Smith S., Hamwi J., Pollari D., Bixby B., Howard J., Singleton J.R. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006, 29:1294-1299.
43. Smith A.G., Rose K., Singleton J.R. Idiopathic neuropathy patients are at high risk for metabolic syndrome. J. Neurol. Sci. 2008, 273:25-28.
44. Sokka A.L., Putkonen N., Mudo G., Pryazhnikov E., Reijonen S., Khiroug L., Belluardo N., Lindholm D., Korhonen L. Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain. J. Neurosci. 2007, 27:901-908.
45. Sparks L.M., Xie H., Koza R.A., Mynatt R., Hulver M.W., Bray G.A., Smith S.R. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005, 54:1926-1933.
46. Stavniichuk R., Drel V.R., Shevalye H., Vareniuk I., Stevens M.J., Nadler J.L., Obrosova I.G. Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies. Free Radic. Biol. Med. 2010, 49:1036-1045.
47. Sumner C.J., Sheth S., Griffin J.W., Cornblath D.R., Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003, 60:108-111.
48. Tesfaye S., Chaturvedi N., Eaton S.E., Ward J.D., Manes C., Ionescu-Tirgoviste C., Witte D.R., Fuller J.H., EURODIAB Prospective Complications Study Group Vascular risk factors and diabetic neuropathy. N. Engl. J. Med. 2005, 352:341-350.
49. Tesfaye S., Boulton A.J., Dyck P.J., Freeman R., Horowitz M., Kempler P., Lauria G., Malik R.A., Spallone V., Vinik A., Bernardi L., Valensi P., Toronto Diabetic Neuropathy Expert Group Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010, 33:2285-2293.
50. Tong X., Hou X., Jourd'heuil D., Weisbrod R.M., Cohen R.A. Upregulation of Nox4 by TGF{beta}1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat. Circ. Res. 2010, 107:975-983.
51. Veves A., Backonja M., Malik R.A. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008, 9:660-674.
52. Vincent A.M., Hayes J.M., McLean L.L., Vivekanandan-Giri A., Pennathur S., Feldman E.L. Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 2009, 58:2376-2385.
53. Watcho P., Stavniichuk R., Ribnicky D.M., Raskin I., Obrosova I.G. High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L. Mediators Inflamm. 2010, 2010:268547.
54. Wei P., Lane P.H., Lane J.T., Padanilam B.J., Sansom S.C. Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes. Diabetologia 2004, 47:1541-1549.
55. Weisberg S.P., Leibel R., Tortoriello D.V. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 2008, 149:3549-3558.
56. Wiggin T.D., Sullivan K.A., Pop-Busui R., Amato A., Sima A.A., Feldman E.L. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 2009, 58:1634-1640.
57. Wu J., Zhang R., Torreggiani M., Ting A., Xiong H., Striker G.E., Vlassara H., Zheng F. Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation. Am. J. Pathol. 2010, 176:2163-2176.
58. Wu C.T., Sheu M.L., Tsai K.S., Chiang C.K., Liu S.H. Salubrinal, an eIF2α dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model. Free Radic. Biol. Med. 2011, 51:671-680.
59. Yagihashi S., Tokui A., Kashiwamura H., Takagi S., Imamura K. In vivo effect of methylcobalamin on the peripheral nerve structure in streptozotocin diabetic rats. Horm. Metab. Res. 1982, 14:10-13.
60. Zawalich W.S., Zawalich K.C., Kelley G.G., Shulman G.I. Islet phosphoinositide hydrolysis and insulin secretory responses from prediabetic fa/fa ZDF rats. Biochem. Biophys. Res. Commun. 1995, 209:974-980.
61. Zhong Y., Li J., Chen Y., Wang J.J., Ratan R., Zhang S.X. Activation of endoplasmic reticulum stress by hyperglycemia is essential for muller cell-derived inflammatory cytokine production in diabetes. Diabetes 2012, 61:492-504.
62. Zhou Y.T., Shimabukuro M., Wang M.Y., Lee Y., Higa M., Milburn J.L., Newgard C.B., Unger R.H. Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:8898-8903.
63. Zhu Y., Fenik P., Zhan G., Sanfillipo-Cohn B., Naidoo N., Veasey S.C. Eif-2a protects brainstem motoneurons in a murine model of sleep apnea. J. Neurosci. 2008, 28:2168-2178.
64. Ziegler D., Sohr C.G., Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 2004, 27:2178-2183.
65. Ziegler D., Rathmann W., Dickhaus T., Meisinger C., Mielck A., KORA Study Group Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med. 2009, 10:393-400.